Discover
CAI
Caris Life Sciences, Inc.
18.75
2 x 17.53
2 x 20.25
bid
ask
+
0.93
5.22%
2 @ 04:00 PM
19.00 +0.25 (1.33%)
| Ytd | -30.50% | |
| 1y | -29.27% |
17.84
day range
19.26
14.19
52 week range
42.50
| Open | 18.09 | Prev Close | 17.82 | Low | 17.84 | High | 19.26 | Mkt Cap | 5.30B |
| Vol | 4.11M | Avg Vol | 2.68M | EPS | -2.76 | P/E | N/A | Forward P/E | 51.27 |
| Beta | N/A | Short Ratio | 4.24 | Inst. Own | 56.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 17.45 | 200-d Avg | 23.23 | 1yr Est | 27.83 |
CAI News
prnewswire.com
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer
Ultra-deep Whole Genome and Whole Transcriptome sequencing combined with sophisticated AI algorithms
benzinga.com
Caris Life Sciences Announces Dual Listing Of Common Shares On NYSE Texas, Effective June 17
Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and
benzinga.com
Caris Life Sciences Announces $100M Buyback Plan
Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-genera
benzinga.com
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows
A selloff in high-flying chipmakers split Wall Street on Thursday, with Broadcom Inc. (NASDAQ:AVGO)‘